TELAVANT HOLDINGS

Summary

Telavant is developing innovative therapies to help patients living with inflammatory and fibrotic diseases.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 5.96 B

Avg. Deal Size£ 5.96 B

Market Context

Senior Management